These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33216039)

  • 21. Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.
    Thompson PD; Rubino J; Janik MJ; MacDougall DE; McBride SJ; Margulies JR; Newton RS
    J Clin Lipidol; 2015; 9(3):295-304. PubMed ID: 26073387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
    Shani M; Dresner J; Vinker S
    Isr Med Assoc J; 2008 May; 10(5):354-7. PubMed ID: 18605358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes.
    Liu G; Shi M; Mosley JD; Weng C; Zhang Y; Lee MTM; Jarvik GP; Hakonarson H; Namjou-Khales B; Sleiman P; Luo Y; Mentch F; Denny JC; Linton MF; Wei WQ; Stein CM; Feng Q
    JAMA Netw Open; 2021 Jun; 4(6):e2112820. PubMed ID: 34097045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article).
    Hyun MH; Jang JW; Choi BG; Na JO; Choi CU; Kim JW; Kim EJ; Rha SW; Park CG; Lee E; Seo HS
    Medicine (Baltimore); 2019 Dec; 98(51):e18510. PubMed ID: 31861037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance.
    Thompson PD; MacDougall DE; Newton RS; Margulies JR; Hanselman JC; Orloff DG; McKenney JM; Ballantyne CM
    J Clin Lipidol; 2016; 10(3):556-67. PubMed ID: 27206943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying the effect of applying the NCEP ATP III criteria in a managed care population treated with statin therapy.
    Quilliam BJ; Perez HE; Andros V; Jones P
    J Manag Care Pharm; 2004; 10(3):244-50. PubMed ID: 15228375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G; Chang CL; Chung K
    Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.
    Kim HS; Wu Y; Lin SJ; Deerochanawong C; Zambahari R; Zhao L; Zhang Q; Yan P
    Curr Med Res Opin; 2008 Jul; 24(7):1951-63. PubMed ID: 18547466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications.
    Azemawah V; Movahed MR; Centuori P; Penaflor R; Riel PL; Situ S; Shadmehr M; Hashemzadeh M
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):625-639. PubMed ID: 31773344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
    Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for a systematic approach to statin switching: an analysis of real-world experience.
    Kakavas PW; McManus JL; Wolfe TA; Guidry T; Flores DN; Ter Riet LB; Glover JJ; Sell H
    J Cardiovasc Nurs; 2013; 28(6):565-72. PubMed ID: 23064180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for cholesterol hyperabsorbers and hyperproducers based on comparative low-density lipoprotein reductions achieved by ezetimibe versus statins.
    Senaratne J; Griffiths J; MacDonald K; Senaratne MP
    J Cardiopulm Rehabil Prev; 2012; 32(5):250-4. PubMed ID: 22785146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.
    Ballantyne CM; McKenney JM; MacDougall DE; Margulies JR; Robinson PL; Hanselman JC; Lalwani ND
    Am J Cardiol; 2016 Jun; 117(12):1928-33. PubMed ID: 27138185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.